| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/10/2002 | WO2001093669A3 Compound screens relating to insulin deficiency or insulin resistance |
| 05/10/2002 | WO2001085993A3 Method for detecting growth hormone variations in humans, the variations and their uses |
| 05/10/2002 | WO2001085201A3 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 05/10/2002 | WO2001079288A3 Cytokine uses; compositions; methods |
| 05/10/2002 | WO2001068697A3 Methods and compositions for immunoregulation |
| 05/10/2002 | WO2001066742A3 G-protein coupled receptors |
| 05/10/2002 | WO2001066594A3 Human protein kinases and protein kinase-like enzymes |
| 05/10/2002 | WO2001064879A3 G-proteins coupled receptor related polypeptides |
| 05/10/2002 | WO2001051087A3 Novel treatment for eye disease |
| 05/10/2002 | WO2001041768A3 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 05/10/2002 | WO2001038326A3 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 05/10/2002 | WO2001034157A9 Protease inhibitors |
| 05/10/2002 | WO2001032709A3 Polypeptides with non-natural primary signalling motifs |
| 05/10/2002 | WO2001029036A3 Allosteric sites on muscarinic receptors |
| 05/10/2002 | WO2001026642A3 Methods and compositions for treating neurobehavioral disorders |
| 05/10/2002 | WO2001025797A3 Methods of evaluating whether a test agent is an agent affecting a leptin receptor |
| 05/10/2002 | WO2001023389A3 Certain alkylene diamine-substituted heterocycles |
| 05/10/2002 | WO2001023386A3 Benzodiazepin derivatives, the production and use thereof |
| 05/10/2002 | WO2001000186A3 New use of 1,2,4-triazolo'1,5-a! pyrimidines |
| 05/10/2002 | WO2000071106A3 Method of treating weight gain |
| 05/10/2002 | WO2000067761A8 Compositions and methods for identifying antigens which elicit an immune response |
| 05/10/2002 | WO2000058339A3 50 human secreted proteins |
| 05/10/2002 | WO2000050639A3 Gene sequence variations with utility in determining the treatment of disease |
| 05/10/2002 | CA2439382A1 Pharmaceutical or dietary composition containing a vegetable oil, in particular olive oil, and sitosterol |
| 05/10/2002 | CA2427568A1 Tricyclic derivatives of indole with antiangiogenic activity |
| 05/10/2002 | CA2427533A1 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 05/10/2002 | CA2427518A1 Polynucleotide encoding an activated human t-lymphocyte-derived protein related to ubiquitin conjugating enzyme |
| 05/10/2002 | CA2427193A1 Food grade transglutaminase inhibitor and uses thereof |
| 05/10/2002 | CA2426977A1 Sulphonamides for the treatment of central nervous system diseases |
| 05/10/2002 | CA2426395A1 Crystalline forms of fluvastatin sodium |
| 05/10/2002 | CA2426284A1 Anti-adiposis composition based on garlic bulb extracts |
| 05/09/2002 | US20020055635 Cycloalkano-indole and -azaindole derivatives |
| 05/09/2002 | US20020055632 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction |
| 05/09/2002 | US20020055630 Process for preparation of cyclopenta [b] [1,4] diazepino [6,7,1-hi] indole derivatives |
| 05/09/2002 | US20020055615 Functional role of adrenomedullin (AM) and the gene-related product (PAMP) in human pathology and physiology |
| 05/09/2002 | US20020055541 Including longistyline A-2-carboxylic acid as a dietary supplement |
| 05/09/2002 | US20020055527 Thiazolium compounds and treatments of disorders associated with protein aging |
| 05/09/2002 | US20020055526 Modulators of SKCa, IKCa and BKCa channels. |
| 05/09/2002 | US20020055523 Inhibiting a PTPase treating type 1 and 2 diabetes, insulin resistance and pathological obesity |
| 05/09/2002 | US20020055516 Nitrogen-containing heterocyclic compounds and medicaments containing the compounds |
| 05/09/2002 | US20020055507 Ureas and thioureas inhibit production of cytokines |
| 05/09/2002 | US20020055504 Acylating a cyclopentaindolemethylamine and cyclizing and reducing the product |
| 05/09/2002 | US20020055493 Phytosterol and/or phytostanol derivatives |
| 05/09/2002 | US20020055479 Treating type 2 diabetes, metabolic disorders, obesity and cancer. |
| 05/09/2002 | US20020055471 Purification step using a brominated polystyrene resin to adsorb anthocyanins |
| 05/09/2002 | US20020055458 Method for the prevention and treatment of retinopathy |
| 05/09/2002 | US20020055142 Major intrinsic protein (MIP)-like polynucleotides, polypeptides, and antibodies |
| 05/09/2002 | US20020054899 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 05/09/2002 | US20020054896 Applying onto healed wound a composition comprising a fluid, film-forming carrier, and subsequently hardening the carrier into a tangible membrane juxtaposed to the healed wound thereby reducing scarring or improving the appearance thereof |
| 05/09/2002 | US20020054881 Variants can be used in specific immunotherapy of allergic pathologies caused by dust mites |
| 05/08/2002 | EP1203769A1 Hypolipidemic 1,4-benzothiazepine derivative |
| 05/08/2002 | EP1203767A1 Heterocyclic-substituted alkylamide acat inhibitors |
| 05/08/2002 | EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 05/08/2002 | EP1203084A1 Microencapsulated nitric oxide synthase source |
| 05/08/2002 | EP1203072A2 Personal care articles |
| 05/08/2002 | EP1203024A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 05/08/2002 | EP1203023A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 05/08/2002 | EP1203015A2 Human chaperone proteins |
| 05/08/2002 | EP1203005A2 25 human secreted proteins |
| 05/08/2002 | EP1202994A1 New compounds |
| 05/08/2002 | EP1202991A1 Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation |
| 05/08/2002 | EP1202990A2 Neurotrophic pyrrolidines and piperidines, and related compositions containing them |
| 05/08/2002 | EP1202989A1 Benzamide derivatives |
| 05/08/2002 | EP1202988A2 Novel integrin receptor antagonists |
| 05/08/2002 | EP1202986A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 05/08/2002 | EP1202980A1 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands |
| 05/08/2002 | EP1202976A1 Pyrazinones, compositions containing such compounds |
| 05/08/2002 | EP1202974A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/08/2002 | EP1202970A1 Cyclic amine derivatives for the treatment of neurological diseases |
| 05/08/2002 | EP1202969A2 Biphenyl derivatives, production thereof and use as medicines |
| 05/08/2002 | EP1202965A1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 05/08/2002 | EP1202964A1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands |
| 05/08/2002 | EP1202738A1 Dihydropyrazine derivatives as npy antagonists |
| 05/08/2002 | EP1202731A2 Method for treating chronic pain using mek inhibitors |
| 05/08/2002 | EP1202726A2 Method for treating chronic pain using mek inhibitors |
| 05/08/2002 | EP1202639A2 Methods for suppressing appetite and enhancing exercise and recovery |
| 05/08/2002 | DE10053813A1 Neue Verwendung von Sulfonamiden New use of sulfonamides |
| 05/08/2002 | CN1348454A Tetracyclic azepinoindole compounds as 5-HT receptor ligands |
| 05/08/2002 | CN1348439A New compounds, their preparation and use |
| 05/08/2002 | CN1348436A Novel ligands of nuclear receptors PPAR's |
| 05/08/2002 | CN1348384A An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport |
| 05/08/2002 | CN1348380A Herbal composition and medicament against diabetes mellitus type II manufactured thereof |
| 05/08/2002 | CN1348375A Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation |
| 05/08/2002 | CN1348372A 药物用途 Drug use |
| 05/08/2002 | CN1348369A Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| 05/08/2002 | CN1348363A Novel pharmaceutical salt form |
| 05/08/2002 | CN1348334A Dietary compositions and methods |
| 05/08/2002 | CN1348008A Production process of compound L-amino acid calcium |
| 05/08/2002 | CN1347714A Chinese herb. medicine composition for treating diabetes and nephropathy and its preparing method |
| 05/08/2002 | CN1347697A Prepn. of cyclic nucleotide nutrient liquid |
| 05/08/2002 | CN1347696A Prepn of composite nucleic acid nutrient liquid |
| 05/08/2002 | CN1347668A Slimming health product producing process |
| 05/08/2002 | CN1084193C Medicine for lowering blood-sugar and nourishing heart and preparing method |
| 05/07/2002 | US6384281 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
| 05/07/2002 | US6384225 Intermediates in the preparation of substituted chroman derivatives |
| 05/07/2002 | US6384220 Antidiabetic agents increasing the expression of glucokinase (gk) to improve glucose tolerance; increase in glucose exposure coupled through gk in beta-cells to increase insulin secretion and in hepatocytes to increase glycogen deposition |
| 05/07/2002 | US6384189 Compositions for stimulating TGF-β activity |
| 05/07/2002 | US6384088 Comprehensive pharmacologic therapy for treatment of obesity |
| 05/07/2002 | US6384087 Materials and methods for the treatment or prevention of obesity |
| 05/07/2002 | US6384086 Administering to host effective amount of storage stable ethene for improving metabolic function |